Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

NCT: NCT04999046 · COMPLETED

NCT IDNCT04999046
StatusCOMPLETED
Start Date2021-10-07
Completion2024-07-31

Brief Summary

To evaluate the safety and efficacy of using NaviFUS™ system in patients with drug resistant epilepsy

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑